uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
5.56
-0.30 (-5.12%)
Nov 4, 2024, 4:00 PM EST - Market closed
uniQure Employees
uniQure had 480 employees as of December 31, 2023. The number of employees decreased by 21 or -4.19% compared to the previous year.
Employees
480
Change (1Y)
-21
Growth (1Y)
-4.19%
Revenue / Employee
$57,723
Profits / Employee
-$593,113
Market Cap
270.76M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Zynex | 1,100 |
AngioDynamics | 748 |
AVITA Medical | 207 |
Vanda Pharmaceuticals | 203 |
Heron Therapeutics | 126 |
Zentalis Pharmaceuticals | 124 |
Atea Pharmaceuticals | 75 |
Inozyme Pharma | 59 |
QURE News
- 20 days ago - uniQure Announces Dosing of First Patient in Phase I/II Clinical Trial of AMT-162 for the Treatment SOD1-ALS - GlobeNewsWire
- 6 weeks ago - uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease - GlobeNewsWire
- 2 months ago - uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease - GlobeNewsWire
- 3 months ago - uniQure: Pullback After Strong Interim Treatment Data Creates Buying Opportunity - Seeking Alpha
- 3 months ago - uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 3 months ago - uniQure Announces Closing of Sale of Manufacturing Facility to Genezen - GlobeNewsWire
- 4 months ago - What Led To A 150% Rise In UniQure Stock In A Week? - Forbes
- 4 months ago - uniQure: Positive HD AMT-130 Treatment Data Leads To Several Other Catalysts - Seeking Alpha